期刊
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 63, 期 25, 页码 2889-2934出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2013.11.002
关键词
ACC/AHA Practice Guideline; biomarkers; pharmacological; cardiovascular disease; cholesterol; diabetes mellitus; drug therapy; hydroxymethylglutaryl,CoA reductase inhibitors/statins; hypercholesterolemia; lipids; patient compliance; primary prevention; risk assessment; risk reduction behavior; secondary prevention